Literature DB >> 4015823

Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases.

A Yoshida, M Ikawa, L C Hsu, K Tani.   

Abstract

Usual human livers contain two major ALDH isozymes, i.e., cytosolic ALDH1 and mitochondrial ALDH2, while approximately 50% of Orientals are "atypical" and have only the ALDH1 and are missing the ALDH2. Instead, the atypical livers contain an enzymatically inactive but immunologically cross-reactive material (CRM) corresponding to the ALDH2 component. Some Orientals are found to be atypical also in the ALDH1 locus, i.e., they are missing the enzymatically active ALDH1 but contain a large amount of CRM corresponding to the ALDH1 component. cDNA for ALDH1 and that for ALDH2 were cloned and their nucleotide sequences were determined. The amino acid sequences of ALDH1 and ALDH2 were deduced from their cDNA sequences. The molecular abnormality of the inactive ALDH2(2) is found to be the substitution of Glu at the 14th position from the COOH-terminal of the protein by Lys which resulted from G----A transition in the gene.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4015823     DOI: 10.1016/0741-8329(85)90024-2

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  12 in total

1.  Ascertainment bias and the pattern of nucleotide diversity at the human ALDH2 locus in a Japanese population.

Authors:  Benjamin T Brown; August Woerner; Jason A Wilder
Journal:  J Mol Evol       Date:  2007-01-16       Impact factor: 2.395

2.  Increase in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cells.

Authors:  R A Canuto; M Ferro; R A Salvo; A M Bassi; A Trombetta; M Maggiora; G Martinasso; R Lindahl; G Muzio
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

3.  Enzymatic activity of atypical Oriental types of aldehyde dehydrogenases.

Authors:  A Yoshida; V Davé
Journal:  Biochem Genet       Date:  1985-08       Impact factor: 1.890

4.  Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo.

Authors:  Che-Hong Chen; Leslie A Cruz; Daria Mochly-Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

5.  An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation.

Authors:  Zhiqiang Chen; Matthew W Foster; Jian Zhang; Lan Mao; Howard A Rockman; Toshihiro Kawamoto; Kyoko Kitagawa; Keiichi I Nakayama; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

6.  Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2.

Authors:  Brian C Jackson; Roger S Holmes; Donald S Backos; Philip Reigan; David C Thompson; Vasilis Vasiliou
Journal:  Chem Biol Interact       Date:  2012-12-13       Impact factor: 5.192

7.  Eliciting the low-activity aldehyde dehydrogenase Asian phenotype by an antisense mechanism results in an aversion to ethanol.

Authors:  E Garver; Q N Cao; M Aini; F Zhou; Y Israel
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

8.  AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.

Authors:  Mao-Wen Weng; Hyun-Wook Lee; Bongkun Choi; Hsiang-Tsui Wang; Yu Hu; Manju Mehta; Dhimant Desai; Shantu Amin; Yi Zheng; Moon-Shong Tang
Journal:  Oncotarget       Date:  2017-03-14

9.  Interaction between ALDH2 rs671 and life habits affects the risk of hypertension in Koreans: A STROBE observational study.

Authors:  Sung-Soo Kim; Sangjung Park; Hyun-Seok Jin
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

10.  Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study.

Authors:  Wei Sen Zhang; Lin Xu; Catherine Mary Schooling; Chao Qiang Jiang; Kar Keung Cheng; Bin Liu; Tai Hing Lam
Journal:  Hypertens Res       Date:  2013-04-25       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.